Epigenetics - Role as Biomarker in Cancer Diagnosis
Received Date: Nov 11, 2017 / Accepted Date: Nov 29, 2017 / Published Date: Dec 05, 2017
Cancer is a disease either caused by genetic mutation or epigenetic modifications at the transcription level. Disease diagnosis at the early stage is a challenging step to be taken care for improving the outcome of patient survival. Latest advances has renewed interest and ended in the development of different potential biomarkers. Biomarkers of cancer include DNA, RNA, proteins, lipids, sugars, small metabolites, cytokinetic and cytogenetic parameters and the entire tumour cells found in the body fluid. Biomarkers should be thoroughly investigated for diagnosing the disease accurately, and to aid in the selective targeted therapies to improve the disease outcome. This review gives a brief description on various biomarkers for diagnosis, prognosis and therapeutic purposes, and how the epigenetic biomarkers act as cancer biomarker effectively.
Keywords: Hypomethylation; Microarrays; Malignant tumors; Chemotherapy
Citation: Manasa (2017) Epigenetics - Role as Biomarker in Cancer Diagnosis. J Oncol Res Treat 2: 114.
Copyright: © 2016 Manasa P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Open Access Journals
- Total views: 3659
- [From(publication date): 0-2017 - Oct 24, 2021]
- Breakdown by view type
- HTML page views: 3223
- PDF downloads: 436